Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-101,400
Closed -$3.53M 4643
2020
Q4
$3.53M Hold
101,400
﹤0.01% 1784
2020
Q3
$1.76M Hold
101,400
﹤0.01% 2213
2020
Q2
$1.67M Sell
101,400
-11,100
-10% -$169K ﹤0.01% 2293
2020
Q1
$1.02M Buy
112,500
+27,300
+32% +$550K ﹤0.01% 2924
2019
Q4
$1.81M Buy
85,200
+2,200
+3% +$48.8K ﹤0.01% 3114
2019
Q3
$1.91M Sell
83,000
-19,500
-19% -$445K ﹤0.01% 2931
2019
Q2
$2.49M Buy
102,500
+24,200
+31% +$498K ﹤0.01% 2654
2019
Q1
$1.01M Buy
78,300
+77,500
+9,688% +$1.36M ﹤0.01% 3383
2018
Q4
$12K Buy
800
+500
+167% +$12.9K ﹤0.01% 6096
2018
Q3
$12K Buy
300
+100
+50% +$4.5K ﹤0.01% 6605
2018
Q2
$10K Sell
200
-1,300
-87% -$73.8K ﹤0.01% 6525
2018
Q1
$90K Sell
1,500
-1,229
-45% -$82K ﹤0.01% 5450
2017
Q4
$215K Sell
2,729
-2,800
-51% -$226K ﹤0.01% 4625
2017
Q3
$464K Buy
5,529
+4,700
+567% +$333K ﹤0.01% 3702
2017
Q2
$54K Buy
829
+400
+93% +$27.2K ﹤0.01% 5303
2017
Q1
$31K Sell
429
-1,365
-76% -$89.7K ﹤0.01% 5584
2016
Q4
$105K Buy
+1,794
New +$94.7K ﹤0.01% 4704

Other funds holding ADNT

Barclays's ADNT Position: Q2 2026 in Review

Barclays reduced its Adient (ADNT) stake by 23% in Q2 2026, selling an estimated $712K and leaving 111,161 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2325.

Barclays first reported a position in ADNT in Q4 2016 and has held it in 39 quarters since. The position peaked at $11.4M in Q4 2023. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Barclays held 111,161 shares of Adient worth $2.04M as of Q2 2026.
  • Barclays sold 33,298 Adient shares in Q2 2026, an estimated $712K.
  • Adient made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2325 holding.
  • Barclays first reported a position in Adient in Q4 2016 and has held it in 39 quarters since.
  • Barclays's Adient position peaked at $11.4M in Q4 2023.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.